Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$637M |
| 2 |
Weyerhaeuser
WY
|
+$340M |
| 3 |
IQVIA
IQV
|
+$132M |
| 4 |
Halliburton
HAL
|
+$123M |
| 5 |
Dover
DOV
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.68B |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$708M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$460M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$293M |
| 5 |
Gilead Sciences
GILD
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Healthcare | 5.12% |
| 3 | Financials | 4.53% |
| 4 | Consumer Discretionary | 4.09% |
| 5 | Communication Services | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LPNT
4326
PUT
DELISTED
LifePoint Health, Inc.
LPNT
| $208K | ﹤0.01% |
+3,600
| New | +$214K |
|
4327
PUT
Cincinnati Financial
CINF
$27.5B
| $207K | ﹤0.01% |
2,700
+1,500
| +125% | +$114K |
|
|
EVRI
4328
DELISTED
Everi Holdings
EVRI
| $207K | ﹤0.01% |
27,242
-18,476
| -40% | -$139K |
|
4329
Invesco CurrencyShares Canadian Dollar Trust
FXC
$69.7M
| $207K | ﹤0.01% |
2,614
-33,443
| -93% | -$2.63M |
|
|
SDRL
4330
CALL
DELISTED
Seadrill Limited Common Stock
SDRL
| $207K | ﹤0.01% |
2,207
+35
| +2% | +$3.05K |
|
4331
Magna International
MGA
$18.1B
| $206K | ﹤0.01% |
3,842
-1,974
| -34% | -$95.7K |
|
|
AKRX
4332
PUT
DELISTED
Akorn Inc
AKRX
| $206K | ﹤0.01% |
+6,200
| New | +$206K |
|
|
CVRR
4333
DELISTED
CVR Refining, LP
CVRR
| $206K | ﹤0.01% |
20,871
-2,941
| -12% | -$24.9K |
|
4334
PUT
Invesco CurrencyShares Swiss Franc Trust
FXF
$396M
| $205K | ﹤0.01% |
2,100
+2,000
| +2,000% | +$197K |
|
4335
Global Partners
GLP
$1.65B
| $205K | ﹤0.01% |
11,796
-1,885
| -14% | -$32.7K |
|
|
PLYA
4336
DELISTED
Playa Hotels & Resorts
PLYA
| $205K | ﹤0.01% |
19,645
+19,045
| +3,174% | +$215K |
|
|
PVLA
4337
Palvella Therapeutics
PVLA
$2.23B
| $205K | ﹤0.01% |
+443
| New | +$189K |
|
|
IPG
4338
CALL
DELISTED
Interpublic Group of Companies
IPG
| $204K | ﹤0.01% |
9,800
-35,000
| -78% | -$761K |
|
4339
PUT
ITT
ITT
$19.2B
| $204K | ﹤0.01% |
4,600
-2,200
| -32% | -$90.6K |
|
|
STML
4340
DELISTED
Stemline Therapeutics, Inc.
STML
| $204K | ﹤0.01% |
18,410
+16,793
| +1,039% | +$158K |
|
|
KMG
4341
DELISTED
KMG Chemicals Inc
KMG
| $204K | ﹤0.01% |
3,709
-1,981
| -35% | -$98.6K |
|
|
BPMC
4342
DELISTED
Blueprint Medicines
BPMC
| $203K | ﹤0.01% |
2,916
+384
| +15% | +$20.5K |
|
4343
Scholastic
SCHL
$753M
| $203K | ﹤0.01% |
5,487
-11,333
| -67% | -$454K |
|
|
SNV
4344
CALL
DELISTED
Synovus
SNV
| $203K | ﹤0.01% |
4,400
+2,500
| +132% | +$108K |
|
4345
PUT
First Majestic Silver
AG
$8.52B
| $202K | ﹤0.01% |
29,600
-15,700
| -35% | -$112K |
|
4346
Community Bank
CBU
$3.44B
| $202K | ﹤0.01% |
3,653
-5,461
| -60% | -$292K |
|
4347
FormFactor
FORM
$9B
| $202K | ﹤0.01% |
11,961
-17,302
| -59% | -$246K |
|
4348
U-Haul Holding Co
UHAL
$14.7B
| $202K | ﹤0.01% |
5,410
-1,810
| -25% | -$67.6K |
|
|
UNT
4349
CALL
DELISTED
UNIT Corporation
UNT
| $202K | ﹤0.01% |
9,800
+2,300
| +31% | +$41.1K |
|
4350
CALL
BCE
BCE
$21.2B
| $201K | ﹤0.01% |
4,300
-4,300
| -50% | -$201K |
|
Similar funds
Barclays's Q3 2017 Portfolio in Review
As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
- Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
- Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
- Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
- Barclays opened 424 new positions and closed 405 in Q3 2017.
- Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.
Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.